Enhancement of Endogenous Plasminogen Activator-induced Thrombolysis by Argatroban and APC and Its Control by TAFI, Measured in An Arterial Thrombolysis Model In Vivo Using Rat Mesenteric Arterioles
- 1 January 2002
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 87 (01), 110-113
- https://doi.org/10.1055/s-0037-1612952
Abstract
Recent in vitro studies have demonstrated that thrombin inhibits fibrinolysis through thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B). We have recently shown that endogenous fibrinolysis in vivo is enhanced by activated protein C (APC) and the selective thrombin inhibitor, argatroban. The aim of the present study was to examine the role of TAFI in these fibrinolytic mechanisms in vivo using purified porcine pancreatic carboxypeptidase B (PPCPB) and a specific TAFIa inhibitor, potato tuber carboxypeptidase B inhibitor (PTCI) in a newly established arterial thrombolysis model. Non-occlusive, mural, platelet-rich thrombi were formed by helium-neon laser irradiation in rat mesenteric arterioles and thrombus size was measured by computerised image analysis. We confirmed that endogenous thrombolysis was enhanced by argatroban (2.0 mg/4 ml/kg/h) or APC (1.62 mg/2.31 ml/kg). PTCI (5.0 mg/2 ml/kg) also accelerated endogenous thrombolysis. PPCPB (3.5 mg/2 ml/kg) inhibited thrombolysis in the absence and presence of argatroban or APC. PTCI tended to further promote APC-induced thrombolysis but the differences did not reach statistical significance. The present findings were in keeping with the results of earlier studies and demonstrated that arterial, platelet-rich thrombi in vivo are degraded by naturally generated plasminogen activators. TAFI may play a significant role in the control of these mechanisms.Keywords
This publication has 17 references indexed in Scilit:
- An Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor Potentiates Tissue-Type Plasminogen Activator-Induced Thrombolysis in a Rabbit Jugular Vein Thrombolysis ModelThrombosis Research, 2000
- Adjuvant Effect of Antibodies against von Willebrand Factor, Fibrinogen, and Fibronectin on Staphylokinase-Induced Thrombolysis as Measured Using Mural Thrombi Formed in Rat Mesenteric VenulesThrombosis Research, 2000
- A Novel Approach to Arterial ThrombolysisBlood, 1999
- A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.JCI Insight, 1998
- Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.JCI Insight, 1997
- ADJUVANT EFFECT OF ARGATROBAN ON STAPHYLOKINASE INDUCED THROMBOLYSIS OF PLATELET RICH THROMBI IN RAT MESENTERIC VENULES IN VIVOThrombosis Research, 1997
- The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvesselsThrombosis Research, 1993
- Antithrombotic Effect of Argatroban on the Pial Vessels of the Rat: A Study with He-Ne Laser-Induced Thrombus FormationPathophysiology of Haemostasis and Thrombosis, 1993
- Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.Circulation, 1989